- Home
- STEP vs ADMA Comparison
STEP vs ADMA Comparison
Compare STEP & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEP
- ADMA
- Stock Information
- Founded
- STEP 2007
- ADMA 2004
- Country
- STEP United States
- ADMA United States
- Employees
- STEP N/A
- ADMA N/A
- Industry
- STEP Finance/Investors Services
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STEP Finance
- ADMA Health Care
- Exchange
- STEP Nasdaq
- ADMA Nasdaq
- Market Cap
- STEP 4.6B
- ADMA 5.1B
- IPO Year
- STEP 2020
- ADMA N/A
- Fundamental
- Price
- STEP $57.01
- ADMA $18.67
- Analyst Decision
- STEP Buy
- ADMA Strong Buy
- Analyst Count
- STEP 7
- ADMA 3
- Target Price
- STEP $65.14
- ADMA $27.67
- AVG Volume (30 Days)
- STEP 551.3K
- ADMA 3.5M
- Earning Date
- STEP 08-07-2025
- ADMA 08-07-2025
- Dividend Yield
- STEP 2.39%
- ADMA N/A
- EPS Growth
- STEP N/A
- ADMA N/A
- EPS
- STEP N/A
- ADMA 0.84
- Revenue
- STEP $1,174,830,000.00
- ADMA $459,381,000.00
- Revenue This Year
- STEP N/A
- ADMA $23.35
- Revenue Next Year
- STEP $21.23
- ADMA $27.67
- P/E Ratio
- STEP N/A
- ADMA $21.87
- Revenue Growth
- STEP 65.09
- ADMA 62.23
- 52 Week Low
- STEP $40.07
- ADMA $10.21
- 52 Week High
- STEP $70.38
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- STEP 56.41
- ADMA 41.64
- Support Level
- STEP $54.54
- ADMA $17.67
- Resistance Level
- STEP $57.18
- ADMA $18.92
- Average True Range (ATR)
- STEP 1.64
- ADMA 0.77
- MACD
- STEP 0.19
- ADMA -0.05
- Stochastic Oscillator
- STEP 91.92
- ADMA 22.25
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.